Lumimicro Co., Ltd acquired an additional 3.54% stake in Kumho HT, Inc. from Douglas Fund 3 for KRW 3.4 billion.
December 24, 2018
Share
Lumimicro Co., Ltd (KOSDAQ:A082800) acquired an additional 3.54% stake in Kumho HT, Inc. (KOSE:A214330) from Douglas Fund 3 for KRW 3.4 billion on December 24, 2018. Lumimicro Co., Ltd acquired 0.43 million shares of Kumho HT, Inc. in cash. Lumimicro Co., Ltd paid KRW 3.4 billion on December 24, 2018. After the transaction, Lumimicro Co., Ltd holds 3.19 million shares amounting to 26.29% stake in Kumho HT, Inc. The Board of Directors passed a resolution for the transaction on December 24, 2018. The transaction is expected to be completed on December 24, 2018.
Lumimicro Co., Ltd (KOSDAQ:A082800) completed the acquisition of an additional 3.54% stake in Kumho HT, Inc. (KOSE:A214330) from Douglas Fund 3 on December 24, 2018.
Vivozon Pharmaceutical Co Ltd , formerly Vivozon Healthcare Inc, is a Korea-based company mainly engaged in the manufacture and sale of finished pharmaceutical products. The Company operates its business through three segments. The Pharmaceutical Business segment is engaged in the manufacture and sale of finished medicines such as external skin preparations, antipyretic analgesic, anti-inflammatory drugs and antidiabetic drugs. The Optical Business segment is engaged in the manufacture and sale of finished products and lighting module sets such as general lighting and automotive lighting using light emitting diode (LED) light sources. The Cosmetics Business segment is engaged in the manufacture and sale of cosmetics and cosmetic ingredients.
VIVOZON PHARMACEUTICAL CO., LTD. 
